Report cover image

Small Cell Lung Cancer (SCLC) Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine

Publisher Prodture
Published Aug 11, 2024
Length 119 Pages
SKU # PROD19315027

Description

Small Cell Lung Cancer (SCLC) Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine


The global small cell lung cancer (SCLC) market is expected to grow at a CAGR of around 8.2% during 2025-2034. This report on global small cell lung cancer (SCLC) market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global small cell lung cancer (SCLC) market by segmenting the market based on treatment type, route of administration, end users, distribution channel and region. Also, detailed profiles of companies operating in the small cell lung cancer (SCLC) market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increased Development of Diversified Treatments
• Increased Healthcare Awareness

Market Challenges

• High Costs

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Route of Administration

• Oral
• Intravenous
• Other Route of Administration

Market by End-User

• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users

Market by Treatment Type

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Radiation Therapy
• Other Treatment Types

Market by Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

119 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Small Cell Lung Cancer (SCLC) Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Small Cell Lung Cancer (SCLC) Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Small Cell Lung Cancer (SCLC) Market by Route of Administration
5.1. Introduction
5.2. Oral
5.3. Intravenous
5.4. Other Route of Administration
6. Global Small Cell Lung Cancer (SCLC) Market by End-User
6.1. Introduction
6.2. Hospitals
6.3. Homecare
6.4. Specialty Clinics
6.5. Other End-Users
7. Global Small Cell Lung Cancer (SCLC) Market by Treatment Type
7.1. Introduction
7.2. Chemotherapy
7.3. Targeted Therapy
7.4. Immunotherapy
7.5. Radiation Therapy
7.6. Other Treatment Types
8. Global Small Cell Lung Cancer (SCLC) Market by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Global Small Cell Lung Cancer (SCLC) Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. Aurobindo Pharma
13.2.2. Bayer AG
13.2.3. CLOVIS Oncology
13.2.4. F. Hoffmann-La Roche Ltd.
13.2.5. GSK plc
13.2.6. Johnson & Johnson Private Limited
13.2.7. Lilly
13.2.8. Lupin
13.2.9. Merck & Co. Inc.
13.2.10. Mylan N.V.
13.2.11. Novartis AG
13.2.12. Pfizer Inc.
13.2.13. Sanofi
13.2.14. Sun Pharmaceutical Industries Ltd.
13.2.15. Teva Pharmaceutical Industries Ltd.
List of Figures
Figure 1: Global Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 2: Global Small Cell Lung Cancer (SCLC) Market by Route of Administration, 2024
Figure 3: Global Small Cell Lung Cancer (SCLC) Market by End-User, 2024
Figure 4: Global Small Cell Lung Cancer (SCLC) Market by Treatment Type, 2024
Figure 5: Global Small Cell Lung Cancer (SCLC) Market by Distribution Channel, 2024
Figure 6: Global Small Cell Lung Cancer (SCLC) Market by Region, 2024
Figure 7: Global Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 8: Global Small Cell Lung Cancer (SCLC) Market by Route of Administration (in %), 2024 & 2034
Figure 9: Global Oral Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 10: Global Oral Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 11: Global Intravenous Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 12: Global Intravenous Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 13: Global Other Route of Administration Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 14: Global Other Route of Administration Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 15: Global Small Cell Lung Cancer (SCLC) Market by End-User (in %), 2024 & 2034
Figure 16: Global Hospitals Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 17: Global Hospitals Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 18: Global Homecare Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 19: Global Homecare Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 20: Global Specialty Clinics Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 21: Global Specialty Clinics Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 22: Global Other End-Users Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 23: Global Other End-Users Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 24: Global Small Cell Lung Cancer (SCLC) Market by Treatment Type (in %), 2024 & 2034
Figure 25: Global Chemotherapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 26: Global Chemotherapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 27: Global Targeted Therapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 28: Global Targeted Therapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 29: Global Immunotherapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 30: Global Immunotherapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 31: Global Radiation Therapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 32: Global Radiation Therapy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 33: Global Other Treatment Types Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 34: Global Other Treatment Types Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 35: Global Small Cell Lung Cancer (SCLC) Market by Distribution Channel (in %), 2024 & 2034
Figure 36: Global Hospital Pharmacy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 37: Global Hospital Pharmacy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 38: Global Online Pharmacy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 39: Global Online Pharmacy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 40: Global Retail Pharmacy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 41: Global Retail Pharmacy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 42: Global Small Cell Lung Cancer (SCLC) Market by Region (in %), 2024 & 2034
Figure 43: Europe Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 44: Europe Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 45: Europe Small Cell Lung Cancer (SCLC) Market by Country (in %), 2024 & 2034
Figure 46: Germany Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 47: United Kingdom Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 48: France Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 49: Italy Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 50: Spain Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 51: Russia Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 52: Netherlands Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 53: North America Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 54: North America Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 55: North America Small Cell Lung Cancer (SCLC) Market by Country (in %), 2024 & 2034
Figure 56: United States Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 57: Canada Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 58: Asia Pacific Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 59: Asia Pacific Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 60: Asia Pacific Small Cell Lung Cancer (SCLC) Market by Country (in %), 2024 & 2034
Figure 61: China Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 62: Japan Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 63: India Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 64: South Korea Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 65: Australia Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 66: Indonesia Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 67: Latin America Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 68: Latin America Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 69: Latin America Small Cell Lung Cancer (SCLC) Market by Country (in %), 2024 & 2034
Figure 70: Mexico Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 71: Brazil Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 72: Argentina Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 73: Middle East & Africa Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2024
Figure 74: Middle East & Africa Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2025-2034
Figure 75: Middle East & Africa Small Cell Lung Cancer (SCLC) Market by Country (in %), 2024 & 2034
Figure 76: Saudi Arabia Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 77: Turkey Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 78: Iran Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 79: UAE Small Cell Lung Cancer (SCLC) Market (in US$ Million), 2020-2034
Figure 80: Market Value Chain
List of Tables
Table 1: Global Small Cell Lung Cancer (SCLC) Market Portraiture
Table 2: Global Small Cell Lung Cancer (SCLC) Market by Route of Administration (in US$ Million), 2024 & 2034
Table 3: Global Small Cell Lung Cancer (SCLC) Market by End-User (in US$ Million), 2024 & 2034
Table 4: Global Small Cell Lung Cancer (SCLC) Market by Treatment Type (in US$ Million), 2024 & 2034
Table 5: Global Small Cell Lung Cancer (SCLC) Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 6: Global Small Cell Lung Cancer (SCLC) Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Small Cell Lung Cancer (SCLC) Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Small Cell Lung Cancer (SCLC) Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Small Cell Lung Cancer (SCLC) Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Small Cell Lung Cancer (SCLC) Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Small Cell Lung Cancer (SCLC) Market by Country (in US$ Million),
2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us